262 related articles for article (PubMed ID: 12915565)
1. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.
Glebe D; Aliakbari M; Krass P; Knoop EV; Valerius KP; Gerlich WH
J Virol; 2003 Sep; 77(17):9511-21. PubMed ID: 12915565
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
Walter E; Keist R; Niederöst B; Pult I; Blum HE
Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
5. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.
Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F
J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes.
Köck J; Baumert TF; Delaney WE; Blum HE; von Weizsäcker F
Hepatology; 2003 Dec; 38(6):1410-8. PubMed ID: 14647052
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri.
Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599
[TBL] [Abstract][Full Text] [Related]
9. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
[TBL] [Abstract][Full Text] [Related]
11. Viral and cellular determinants involved in hepadnaviral entry.
Glebe D; Urban S
World J Gastroenterol; 2007 Jan; 13(1):22-38. PubMed ID: 17206752
[TBL] [Abstract][Full Text] [Related]
12. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri.
Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K
Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415
[TBL] [Abstract][Full Text] [Related]
13. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.
Fernholz D; Galle PR; Stemler M; Brunetto M; Bonino F; Will H
Virology; 1993 May; 194(1):137-48. PubMed ID: 8480417
[TBL] [Abstract][Full Text] [Related]
14. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
Toita R; Kawano T; Kang JH; Murata M
World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
[TBL] [Abstract][Full Text] [Related]
15. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.
Lu X; Block TM; Gerlich WH
J Virol; 1996 Apr; 70(4):2277-85. PubMed ID: 8642654
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain.
Budkowska A; Bedossa P; Groh F; Louise A; Pillot J
J Virol; 1995 Feb; 69(2):840-8. PubMed ID: 7815551
[TBL] [Abstract][Full Text] [Related]
17. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
18. Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B.
Suzuki K; Uchida T; Shikata T; Moriyama M; Arakawa Y; Mizokami M; Mima F
Liver; 1990 Dec; 10(6):355-64. PubMed ID: 2074733
[TBL] [Abstract][Full Text] [Related]
19. A systematic study of Tupaia as a model for human acute hepatitis B infection.
Li J; Shi TD; Han JF; Zeng XG; Fan CL; Han C; Liu HL; Wu YZ
J Vet Med Sci; 2021 Jul; 83(6):1004-1011. PubMed ID: 33952781
[TBL] [Abstract][Full Text] [Related]
20. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
